Virginia Powers

The addition of Onivyde to some chemotherapy regimens for pancreatic cancer improved survival and did not affect patients' quality of life.

The first-line treatment paradigm for lung cancer is shifting.

Though having a high body mass index (BMI) is associated with a higher risk for colorectal cancer, patients who are thinner may not do as well after treatment for metastatic colorectal cancer (mCRC).